Sangamo Therapeutics, Inc.

📍 Brisbane, United States🗓 Founded 1995👥 437 employees💰 Last funded Dec 2019
Biotechnology Research🌐 sangamo.com
Website LinkedIn
For Sangamo Therapeutics, science is a means to develop new medicines with the potential to transform the lives of patients living with serious genetic diseases. Our scientists are leaders in the discovery, research and development of technologies enabling gene-based therapeutic development. Currently we are conducting clinical trials, including the first ever in vivo human genome editing studies. To learn more about Sangamo, visit the our website at www.sangamo.com.
4
Total investors
0
Early stage
0
Mid stage
0
Late stage
1995
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
4
Investor activity2017–2019 · investors recorded per year
201712018120192
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Sangamo Therapeutics, Inc.?
Sangamo Therapeutics, Inc. has 4 investors on record on gritt.io.
When did Sangamo Therapeutics, Inc. last raise funding?
The most recent investment in Sangamo Therapeutics, Inc. recorded on gritt.io was in December 2019.
When was Sangamo Therapeutics, Inc. founded?
Sangamo Therapeutics, Inc. was founded in 1995.
What industry is Sangamo Therapeutics, Inc. in?
Sangamo Therapeutics, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Sangamo Therapeutics, Inc. based?
Sangamo Therapeutics, Inc. is headquartered in Brisbane, United States.